Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Indian Willow Bark (Salix tetrasperma) contains salicin, a precursor to salicylic acid, alongside flavonoids and tannins, which exert anti-inflammatory and analgesic effects. Its primary mechanism involves inhibiting COX-1 and COX-2 enzymes and other pro-inflammatory mediators, offering multi-target action.
Reported Benefits (Provisional)
Origin & History
Indian Willow Bark (Salix tetrasperma) is native to South Asia, particularly India, Sri Lanka, and parts of Southeast Asia, thriving in tropical and subtropical forests. This botanical is traditionally revered for its potent anti-inflammatory, pain-relieving, and immune-boosting properties, supporting systemic resilience and vitality.
Research Narrative (Provisional)
Research on Indian Willow Bark (Salix tetrasperma) primarily focuses on its salicin content, which is metabolized into salicylic acid, providing anti-inflammatory and analgesic effects. Studies support its traditional uses for pain relief and inflammation, with emerging evidence for its antioxidant and metabolic benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Salicin, flavonoids, polyphenols, tannins, saponins, alkaloids, lignans, catechins. - Vitamins: Vitamin A, Vitamin C, Vitamin K. - Minerals: Magnesium, potassium, calcium.
Reported Mechanism (Provisional)
Indian Willow Bark's primary bioactive, salicin, is metabolized into salicylic acid, which non-selectively inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis and thereby alleviating pain and inflammation. Additionally, it contains flavonoids, chalcone glycosides, and polyphenols that contribute to its anti-inflammatory effects by inhibiting 5-lipoxygenase (5-LOX), modulating transcription factors, and providing antioxidant support. This multi-target approach reduces pro-inflammatory cytokine production and oxidative stress.
Clinical Narrative (Provisional)
While specific clinical trials on Salix tetrasperma are less common, research on related Salix species, which share similar phytochemical profiles, supports the traditional uses of willow bark for pain and inflammation. Studies often demonstrate efficacy in chronic low back pain, osteoarthritis, and other inflammatory conditions, with extract doses typically standardized to salicin content. Emerging evidence also highlights its antioxidant properties, contributing to cardiovascular and metabolic health benefits, though more direct human clinical trials on S. tetrasperma are needed to fully elucidate its therapeutic potential.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.